Tricyclo-DNA containing oligonucleotides as steric block inhibitors of human immunodeficiency virus type 1 tat-dependent trans-activation and HIV-1 infectivity
- PMID: 17461763
- DOI: 10.1089/oli.2006.0046
Tricyclo-DNA containing oligonucleotides as steric block inhibitors of human immunodeficiency virus type 1 tat-dependent trans-activation and HIV-1 infectivity
Abstract
Replication of human immunodeficiency virus type 1 (HIV-1) is controlled by a variety of viral and host proteins. The viral protein Tat acts in concert with host cellular factors to stimulate transcriptional elongation from the viral long terminal repeat (LTR) through a specific interaction with a 59-residue stem-loop RNA known as the trans-activation responsive element (TAR). Inhibitors of Tat-TAR recognition are expected to block transcription and suppress HIV-1 replication. In previous studies, we showed that 2'-O-methyl (OMe) oligonucleotide mixmers containing locked nucleic acid (LNA) residues are powerful steric block inhibitors of Tat-dependent trans-activation in a HeLa cell reporter system. Here we compare OMe/LNA mixmer oligonucleotides with oligonucleotides containing tricyclo-DNAs and their mixmers with OMe residues in four different assays: (1) binding to the _target TAR RNA, (2) Tat-dependent in vitro transcription from an HIV-1 DNA template directed by HeLa cell nuclear extract, (3) trans-activation inhibition in HeLa cells containing a stably integrated firefly luciferase reporter gene under HIV-1 LTR control, and (4) an anti-HIV beta-galactosidase reporter assay of viral infection. Although tricyclo-DNA oligonucleotides bound TAR RNA more weakly, they were as good as OMe/LNA oligonucleotides in suppressing in vitro transcription and trans-activation in HeLa cells when delivered by cationic lipid. No inhibition of in vitro transcription and trans-activation in HeLa cells was observed for tricyclo-DNA/OMe mixmers, even though their affinities to TAR RNA were strong and their cell distributions did not differ from oligonucleotides containing all or predominantly tricyclo-DNA residues. Tricyclo-DNA 16-mer showed sequence-specific inhibition of beta-galactosidase expression in an anti-HIV HeLa cell reporter assay.
Similar articles
-
A structure-activity study of the inhibition of HIV-1 Tat-dependent trans-activation by mixmer 2'-O-methyl oligoribonucleotides containing locked nucleic acid (LNA), alpha-L-LNA, or 2'-thio-LNA residues.Oligonucleotides. 2003;13(6):435-53. doi: 10.1089/154545703322860762. Oligonucleotides. 2003. PMID: 15025911
-
Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2'-O-methyl/LNA oligoribonucleotides.Biochemistry. 2001 Dec 4;40(48):14645-54. doi: 10.1021/bi011279e. Biochemistry. 2001. PMID: 11724578
-
Comparative studies of tricyclo-DNA- and LNA-containing oligonucleotides as inhibitors of HIV-1 gene expression.Nucleosides Nucleotides Nucleic Acids. 2007;26(6-7):747-50. doi: 10.1080/15257770701490928. Nucleosides Nucleotides Nucleic Acids. 2007. PMID: 18066894
-
Discoveries of Tat-TAR interaction inhibitors for HIV-1.Curr Drug _targets Infect Disord. 2005 Dec;5(4):433-44. doi: 10.2174/156800505774912901. Curr Drug _targets Infect Disord. 2005. PMID: 16535863 Review.
-
Tackling Tat.J Mol Biol. 1999 Oct 22;293(2):235-54. doi: 10.1006/jmbi.1999.3060. J Mol Biol. 1999. PMID: 10550206 Review.
Cited by
-
MicroRNAs and Long Noncoding RNAs as Novel Therapeutic _targets in Estrogen Receptor-Positive Breast and Ovarian Cancers.Int J Mol Sci. 2021 Apr 15;22(8):4072. doi: 10.3390/ijms22084072. Int J Mol Sci. 2021. PMID: 33920789 Free PMC article. Review.
-
Cell-Penetrating Peptide Conjugates of Steric Blocking Oligonucleotides as Therapeutics for Neuromuscular Diseases from a Historical Perspective to Current Prospects of Treatment.Nucleic Acid Ther. 2019 Feb;29(1):1-12. doi: 10.1089/nat.2018.0747. Epub 2018 Oct 16. Nucleic Acid Ther. 2019. PMID: 30307373 Free PMC article. Review.
-
The Use of Tricyclo-DNA Oligomers for the Treatment of Genetic Disorders.Biomedicines. 2017 Dec 22;6(1):2. doi: 10.3390/biomedicines6010002. Biomedicines. 2017. PMID: 29271929 Free PMC article. Review.
-
Therapeutic Potential of Tricyclo-DNA antisense oligonucleotides.J Neuromuscul Dis. 2016 May 27;3(2):157-167. doi: 10.3233/JND-160146. J Neuromuscul Dis. 2016. PMID: 27854216 Free PMC article. Review.
-
Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers.Nat Med. 2015 Mar;21(3):270-5. doi: 10.1038/nm.3765. Epub 2015 Feb 2. Nat Med. 2015. PMID: 25642938
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous